A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma

We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single-cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.

[1]  James M. McFarland,et al.  Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division , 2020, Proceedings of the National Academy of Sciences.

[2]  N. Gilbert,et al.  The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress , 2020, eLife.

[3]  G. Reid,et al.  YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms , 2020, Cancers.

[4]  Jordan F Hastings,et al.  Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma , 2020, eLife.

[5]  Jordan F Hastings,et al.  Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma , 2020, Frontiers in Cell and Developmental Biology.

[6]  M. Malumbres,et al.  CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma. , 2020, Cancer cell.

[7]  S. Mirarab,et al.  Sequence Analysis , 2020, Encyclopedia of Bioinformatics and Computational Biology.

[8]  F. Worden,et al.  A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma , 2020, Investigational New Drugs.

[9]  A. Smogorzewska.  Fanconi Anemia: A Paradigm for Understanding DNA Repair During Replication. , 2019, Blood.

[10]  C. Elizabeth Caldon,et al.  Label free, quantitative single-cell fate tracking of time-lapse movies , 2019, MethodsX.

[11]  Steven J. Altschuler,et al.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy , 2019, Cell.

[12]  Y. Pommier,et al.  PARP Trapping Beyond Homologous Recombination and Platinum Sensitivity in Cancers , 2019, Annual Review of Cancer Biology.

[13]  Julian Spies,et al.  53BP1 nuclear bodies enforce replication timing at under-replicated DNA to limit heritable DNA damage , 2019, Nature Cell Biology.

[14]  R. Medema,et al.  Persistent repair intermediates induce senescence , 2018, Nature Communications.

[15]  S. West,et al.  A new class of ultrafine anaphase bridges generated by homologous recombination , 2018, Cell cycle.

[16]  J. R. Paulson,et al.  An intrinsic S/G2 checkpoint enforced by ATR , 2018, Science.

[17]  W. Vermeulen,et al.  Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage , 2018, Nucleic acids research.

[18]  Jordan F Hastings,et al.  Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy , 2018, Science Translational Medicine.

[19]  Eugene W. Myers,et al.  Cell Detection with Star-convex Polygons , 2018, MICCAI.

[20]  David R. Croucher,et al.  MASTL overexpression promotes chromosome instability and metastasis in breast cancer , 2018, Oncogene.

[21]  A. Ashworth,et al.  Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial , 2018, Nature Medicine.

[22]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[23]  C. Swanton,et al.  Determinants and clinical implications of chromosomal instability in cancer , 2018, Nature Reviews Clinical Oncology.

[24]  Sean C Warren,et al.  A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts. , 2017, Cell reports.

[25]  A. Castro,et al.  Ensa controls S-phase length by modulating Treslin levels , 2017, Nature Communications.

[26]  Chris Bakal,et al.  DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression , 2017, Nature Communications.

[27]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[28]  Petr Danecek,et al.  BCFtools/csq: haplotype-aware variant consequences , 2016, bioRxiv.

[29]  S. Jalal,et al.  DNA repair in lung cancer: potential not yet reached. , 2016, Lung cancer management.

[30]  Brett J. Roberts,et al.  Cell fate determination in cisplatin resistance and chemosensitization , 2016, Oncotarget.

[31]  R. Weissleder,et al.  Single cell resolution in vivo imaging of DNA damage following PARP inhibition , 2015, Scientific Reports.

[32]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[33]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[34]  Samuel Rogers,et al.  Stressing Mitosis to Death , 2014, Front. Oncol..

[35]  A. Castro,et al.  Partial inhibition of Cdk1 in G2 phase overrides the SAC and decouples mitotic events , 2014, Cell cycle.

[36]  William T. Silkworth,et al.  The mitotic origin of chromosomal instability , 2014, Current Biology.

[37]  M. Hayashi,et al.  DNA damage associated with mitosis and cytokinesis failure , 2013, Oncogene.

[38]  Jacco van Rheenen,et al.  Surgical implantation of an abdominal imaging window for intravital microscopy , 2013, Nature Protocols.

[39]  A. Castro,et al.  Quantitative Live Imaging of Endogenous DNA Replication in Mammalian Cells , 2012, PloS one.

[40]  Ran Kafri,et al.  Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. , 2012, Molecular cell.

[41]  J. Jiricny,et al.  Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis , 2012, Nucleic acids research.

[42]  A. Cardona,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[43]  Michael Thomaschewski,et al.  RGB marking with lentiviral vectors for multicolor clonal cell tracking , 2012, Nature Protocols.

[44]  N. Volkow,et al.  Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain , 2011, Molecular Psychiatry.

[45]  Michael Thomaschewski,et al.  RGB marking facilitates multicolor clonal cell tracking , 2011, Nature Medicine.

[46]  Simon Anders,et al.  Differential expression analysis for sequence count data , 2010, Genome Biology.

[47]  Bojana Gligorijevic,et al.  Dendra2 Photoswitching through the Mammary Imaging Window , 2009, Journal of visualized experiments : JoVE.

[48]  D. Gerlich,et al.  Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization , 2009, Cell.

[49]  Jacco van Rheenen,et al.  Intravital imaging of metastatic behavior through a mammary imaging window , 2008, Nature Methods.

[50]  B. Fehse,et al.  A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[52]  D. Stewart,et al.  Mechanisms of resistance to cisplatin and carboplatin. , 2007, Critical reviews in oncology/hematology.

[53]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[54]  F. Lokiec,et al.  Population pharmacokinetics of total and unbound plasma cisplatin in adult patients. , 2004, British journal of clinical pharmacology.

[55]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[56]  J. Piette,et al.  Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts , 2003, The EMBO journal.

[57]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[58]  J. Roth,et al.  Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner , 2000, Oncogene.

[59]  J. Fagerberg,et al.  Pharmacokinetics of cisplatin and its monohydrated complex in humans. , 1996, Journal of pharmaceutical sciences.

[60]  R. Prieto-Diaz,et al.  Breathing new life , 1988 .

[61]  J. Deragon,et al.  Moderated estimation of fold change and dispersion for RNA-seq data , 2020 .

[62]  I. Hickson,et al.  Knotty Problems during Mitosis: Mechanistic Insight into the Processing of Ultrafine DNA Bridges in Anaphase. , 2017, Cold Spring Harbor symposia on quantitative biology.

[63]  MICHAEL J. R. Stark.  Cell fate determination , 2016 .

[64]  Atsushi Miyawaki,et al.  [Visualizing spatiotemporal dynamics of multicellular cell-cycle progression]. , 2012, Seikagaku. The Journal of Japanese Biochemical Society.

[65]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[66]  M. Wilkins.  Biology and Management , 1998 .